NIDARSAN VISWANATHAN

Senior Resident | Assistant Professor

Qualification

MBBS | M.D

Contact Info

[email protected]

Bio

Hi all,I completed my postgraduation in MD Pharmacology from SRIHER, Chennai with Goldvmedal in MD Final examination,2021. In the same year I joined SRIHER, currently working as Senior Resident with a passion for learning, teaching and research in basic science. My areas of academic interests include pharmacovigilance ,clinical trials and invitro cell line studies. I am currently assigned the role of Pharmacology subject incharge for MBBS IInd year. Previously I was subject incharge for courses like Bsc Courses  I have been a speaker, moderator and judge in various Pharmacology postgraduate academic programmes. I was the organising secretary of ASPIRE 2023-Annual Rapid Review Course for MD Pharmacology postgraduates from across the country .
Apart from academics,I am a member of SRIHER University Faculty Cricket and Football team and have represented the university in various intraand inter university tournaments in IIT DirectorsTrophy at IIT Madras, Prof Bennet Albert CricketTournament at MCC,Tambaram ,Tamil Nadu Doctors Premier League(TNDPL).

Educations

Dr Nidarsan completed M.B.B.S in  2015 from Sree Gokulam Medical College and Research Foundation, Venjaramoodu,Thiruvananthapuram, Kerala and M.D. Pharmacology with Gold Medal in 2021 from Sri Ramachandra Institute Of Higher Education and Research, Porur, Chennai.

Research Interest

Projects

An invitro evaluation of anticancer activity of BCL-2 inhibitor Venetoclax in solid tumors using PA-1 ovarian cancer cell line

Bcl-2 family of proteins play a key role in regulation of apoptosis. They are currently being targeted as a promising therapeutic opportunity in cancer therapy. Venetoclax is a new highly selective inhibitor of Bcl-2 protein which is approved in treatment of hematological malignancies. The evidence related to effectiveness of Bcl-2 inhibitors in solid tumors is yet to be widely established. Hence the potential role of venetoclax in treatment of solid tumors is being investigated in this study using PA -1 ovarian cancer cell line. This study aims to evaluate the anticancer activity of  Bcl-2 inhibitor Venetoclax in solid tumors using PA-1 ovarian cancer cell line.

Awards & Recognitions

Dr Hema Sudhakar Gold Medal

Received gold medal for highest mark in MD Pharmacology University examination-2021 from honorable Governor of Tamil Nadu.

Dr Hema Sudhakar Gold Medal

Sports-Second place in IT Directors Trophy at IIT Madras, Prof Bennet Albert CricketTournament at MCC,Tambaram,Ramachandra Premier League

News

Membership

Admissions